Cited by 313

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Hit Identification and Optimization in Virtual Screening: Practical Recommendations Based on a Critical Literature Analysis: Miniperspective

Open access

Zhu, Tian, Cao, Shuyi, Su, Pin-Chih, Patel, Ram, Shah, Darshan, Chokshi, Heta B., Szukala, Richard, Johnson, Michael E., Hevener, Kirk E.·2013·Journal of Medicinal Chemistry

DOI 10.1021/jm301916b

Open this paper in CoChat — free account

Abstract

A critical analysis of virtual screening results published between 2007 and 2011 was performed. The activity of reported hit compounds from over 400 studies was compared to their hit identification criteria. Hit rates and ligand efficiencies were calculated to assist in these analyses, and the results were compared with factors such as the size of the virtual library and the number of compounds tested. A series of promiscuity, druglike, and ADMET filters were applied to the reported hits to assess the quality of compounds reported, and a careful analysis of a subset of the studies that presented hit optimization was performed. These data allowed us to make several practical recommendations with respect to selection of compounds for experimental testing, definition of hit identification criteria, and general virtual screening hit criteria to allow for realistic hit optimization. A key recommendation is the use of size-targeted ligand efficiency values as hit identification criteria.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1021/jm301916b

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
The druggable genome
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties
Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300367a · Cited by 2,222
Ligand efficiency: a useful metric for lead selection
Hopkins, A. L., Groom, C. R., & Alex, A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03069-7 · Cited by 1,846
A Critical Assessment of Docking Programs and Scoring Functions
Warren, G. L., Andrews, C. W., Capelli, A.-M., Clarke, B., LaLonde, J., Lambert, M. H., Lindvall, M., Nevins, N., Semus, S. F., Senger, S., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050362n · Cited by 1,814
Chemical Similarity Searching
Willett, P., Barnard, J. M., & Downs, G. M. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci9800211 · Cited by 1,765
Evaluating Virtual Screening Methods: Good and Bad Metrics for the “Early Recognition” Problem
Truchon, J.-F., & Bayly, C. I. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600426e · Cited by 874
The maximal affinity of ligands
Kuntz, I. D., Chen, K., Sharp, K. A., & Kollman, P. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.9997 · Cited by 849
Is There a Difference between Leads and Drugs? A Historical Perspective
Oprea, T. I., Davis, A. M., Teague, S. J., & Leeson, P. D. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010366a · Cited by 769
On Outliers and Activity CliffsWhy QSAR Often Disappoints
Maggiora, G. M. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060117s · Cited by 728
Efficient Drug Lead Discovery and Optimization
Jorgensen, W. L. (2009) · Accounts of Chemical Research · doi:10.1021/ar800236t · Cited by 649
High-throughput screening assays for the identification of chemical probes
Inglese, J., Johnson, R. L., Simeonov, A., Xia, M., Zheng, W., Austin, C. P., & Auld, D. S. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.17 · Cited by 614
Probing the links between in vitro potency, ADMET and physicochemical parameters
Gleeson, M. P., Hersey, A., Montanari, D., & Overington, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3367 · Cited by 503
Molecular Docking and High-Throughput Screening for Novel Inhibitors of Protein Tyrosine Phosphatase-1B
Doman, T. N., McGovern, S. L., Witherbee, B. J., Kasten, T. P., Kurumbail, R., Stallings, W. C., Connolly, D. T., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010548w · Cited by 462
Fragment-Based Approaches in Drug Discovery and Chemical Biology
Scott, D. E., Coyne, A. G., Hudson, S. A., & Abell, C. (2012) · Biochemistry · doi:10.1021/bi3005126 · Cited by 460
Prediction of ‘drug-likeness’
Walters, W. P., & Murcko, M. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00003-0 · Cited by 439
Recognizing Pitfalls in Virtual Screening: A Critical Review
Scior, T., Bender, A., Tresadern, G., Medina-Franco, J. L., Martínez-Mayorga, K., Langer, T., Cuanalo-Contreras, K., & Agrafiotis, D. K. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200528d · Cited by 438
VolSurf: a new tool for the pharmacokinetic optimization of lead compounds
Cruciani, G., Pastor, M., & Guba, W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00162-7 · Cited by 419
Exploring Activity Cliffs in Medicinal Chemistry: Miniperspective
Stumpfe, D., & Bajorath, J. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201706b · Cited by 374
Designing screens: how to make your hits a hit
Walters, W. P., & Namchuk, M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1063 · Cited by 374
In silico pharmacology for drug discovery: applications to targets and beyond
Ekins, S., Mestres, J., & Testa, B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707306 · Cited by 365
The Scaffold Tree − Visualization of the Scaffold Universe by Hierarchical Scaffold Classification
Schuffenhauer, A., Ertl, P., Roggo, S., Wetzel, S., Koch, M. A., & Waldmann, H. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600338x · Cited by 364
Rules for Identifying Potentially Reactive or Promiscuous Compounds
Bruns, R. F., & Watson, I. A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301008n · Cited by 338
Ligand Binding Efficiency: Trends, Physical Basis, and Implications
Reynolds, C. H., Tounge, B. A., & Bembenek, S. D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701255b · Cited by 319
Fragment-Based Drug Design: How Big Is Too Big?
Hajduk, P. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060511h · Cited by 265
Quo Vadis, Virtual Screening? A Comprehensive Survey of Prospective Applications
Ripphausen, P., Nisius, B., Peltason, L., & Bajorath, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101020z · Cited by 262
Complementarity Between a Docking and a High-Throughput Screen in Discovering New Cruzain Inhibitors
Ferreira, R. S., Simeonov, A., Jadhav, A., Eidam, O., Mott, B. T., Keiser, M. J., McKerrow, J. H., Maloney, D. J., Irwin, J. J., & Shoichet, B. K. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100488w · Cited by 247
State-of-the-art in ligand-based virtual screening
Ripphausen, P., Nisius, B., & Bajorath, J. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.011 · Cited by 240
Virtual Screening and Its Integration with Modern Drug Design Technologies
Andricopulo, A., Guido, R., & Oliva, G. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783330683 · Cited by 209
Virtual screening for novel quorum sensing inhibitors to eradicate biofilm formation of Pseudomonas aeruginosa
Zeng, Z., Qian, L., Cao, L., Tan, H., Huang, Y., Xue, X., Shen, Y., & Zhou, S. (2008) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-008-1406-5 · Cited by 179
Comprehensive Mechanistic Analysis of Hits from High-Throughput and Docking Screens against β-Lactamase
Babaoglu, K., Simeonov, A., Irwin, J. J., Nelson, M. E., Feng, B., Thomas, C. J., Cancian, L., Costi, M. P., Maltby, D. A., Jadhav, A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701500e · Cited by 178
Consideration of Molecular Weight during Compound Selection in Virtual Target-Based Database Screening
Pan, Y., Huang, N., Cho, S., & MacKerell, A. D. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci020055f · Cited by 162
An improved malachite green assay of phosphate: Mechanism and application
Feng, J., Chen, Y., Pu, J., Yang, X., Zhang, C., Zhu, S., Zhao, Y., Yuan, Y., Yuan, H., & Liao, F. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.10.025 · Cited by 118
Rational Methods for the Selection of Diverse Screening Compounds
Huggins, D. J., Venkitaraman, A. R., & Spring, D. R. (2011) · ACS Chemical Biology · doi:10.1021/cb100420r · Cited by 118
Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation
Abad‐Zapatero, C., Perišić, O., Wass, J. A. H., Bento, A. P., Overington, J. P., Al‐Lazikani, B., & Johnson, M. E. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.004 · Cited by 116
Self-citation
Pharmacophore‐Based Discovery of Small‐Molecule Inhibitors of Protein–Protein Interactions between HIV‐1 Integrase and Cellular Cofactor LEDGF/p75
Luca, L. D., Barreca, M. L., Ferro, S., Christ, F., Iraci, N., Gitto, R., Monforte, A., Debyser, Z., & Chimirri, A. (2009) · ChemMedChem · doi:10.1002/cmdc.200900070 · Cited by 100
Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening
Kalid, O., Mense, M., Fischman, S., Shitrit, A., Bihler, H. J., Ben‐Zeev, E., Schutz, N. C., Pedemonte, N., Thomas, P., Bridges, R. J., et al. (2010) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-010-9390-0 · Cited by 94
Search for Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase Using Chemical Similarity, Molecular Docking, and MM-GB/SA Scoring
Barreiro, G., Guimarães, C. R. W., Tubert‐Brohman, I., Lyons, T. M., Tirado‐Rives, J., & Jorgensen, W. L. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700271z · Cited by 90
Identifying Actives from HTS Data Sets: Practical Approaches for the Selection of an Appropriate HTS Data-Processing Method and Quality Control Review
Shun, T. Y., Lazo, J. S., Sharlow, E. R., & Johnston, P. A. (2010) · SLAS DISCOVERY · doi:10.1177/1087057110389039 · Cited by 83
Comprehensive Assessment of ADMET Risks in Drug Discovery
Wang, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682514 · Cited by 70
Discovery and Optimization of a Novel Spiropyrrolidine Inhibitor of β-Secretase (BACE1) through Fragment-Based Drug Design
Efremov, I. V., Vajdos, F. F., Borzilleri, K. A., Capetta, S. H., Chen, H., Dorff, P. H., Dutra, J. K., Goldstein, S. W., Mansour, M. N., McColl, A. S., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201715d · Cited by 65
Extending the Activity Cliff Concept: Structural Categorization of Activity Cliffs and Systematic Identification of Different Types of Cliffs in the ChEMBL Database
Hu, Y., & Bajorath, J. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300274c · Cited by 63
Unbiasing Scoring Functions: A New Normalization and Rescoring Strategy
Carta, G., Knox, A. J. S., & Lloyd, D. G. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600471m · Cited by 59
NovelN-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1mAChR Agonists
Budzik, B., Garzya, V., Shi, D., Walker, G., Woolley-Roberts, M., Pardoe, J., Lucas, A. J., Tehan, B. G., Rivero, R. A., Langmead, C. J., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100105x · Cited by 55
Combined Approach Using Ligand Efficiency, Cross-Docking, and Antitarget Hits for Wild-Type and Drug-Resistant Y181C HIV-1 Reverse Transcriptase
García‐Sosa, A. T., Sild, S., Takkis, K., & Maran, U. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200203h · Cited by 27
Discovery of Novel and Cardioselective Diltiazem-like Calcium Channel Blockers via Virtual Screening
Carosati, E., Budriesi, R., Ioan, P., Ugenti, M. P., Frosini, M., Fusi, F., Corda, G., Cosimelli, B., Spinelli, D., Chiarini, A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800151n · Cited by 26
Compound Selection for Virtual Screening
Oprea, T. I., Bologa, C., & Olah, M. (2005) · Drug discovery series · doi:10.1201/9781420028775.pt2 · Cited by 13

Artificial intelligence in drug development: Present status and future prospects
Mak, K.-K., & Pichika, M. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.014 · Cited by 1,018
In silico methods and tools for drug discovery
Shaker, B., Ahmad, S., Lee, J., Jung, C., & Na, D. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104851 · Cited by 607
Amelioration of Alzheimer’s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow
Xie, C., Zhuang, X.-X., Niu, Z., Ai, R., Lautrup, S., Zheng, S., Jiang, Y., Han, R., Gupta, T. S., Cao, S., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00819-5 · Cited by 336
Self-citation
Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics
Koromina, M., Pandi, M.-T., & Patrinos, G. P. (2019) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2019.0151 · Cited by 140
Best Practices of Computer-Aided Drug Discovery: Lessons Learned from the Development of a Preclinical Candidate for Prostate Cancer with a New Mechanism of Action
Ban, F., Dalal, K., Li, H., LeBlanc, E., Rennie, P. S., & Cherkasov, A. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00137 · Cited by 109

See all 313

Authors: Zhu, T., Cao, S., Su, P.-C., Patel, R., Shah, D., Chokshi, H. B., Szukala, R., Johnson, M. E., & Hevener, K. E.
Venue: Journal of Medicinal Chemistry
Publisher: American Chemical Society (ACS)
Published: 2013-06-07
Volume: 56
Issue: 17
Pages: 6560-6572
ISSN: 0022-2623 (ISSN-L)
1520-4804
DOI: 10.1021/jm301916b
OpenAlex: W2175130792
Cited by: 313
References: 51
FWCI: 15.93
Type: journal article
Language: en
Open access: green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Hit Identification and Optimization in Virtual Screening: Practical Recommendations Based on a Critical Literature Analysis: Miniperspective

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources